dolastatin analog (Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedolastatin analog (Roche)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTubulin inhibitorsCell cycle inhibitorsMicrotubule inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerlandJapan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A